|
Match
|
Document |
Document Title |
|
|
9018222 |
Use of sodium channel blockers for the treatment of neuropathic pain developing as a consequence of chemotherapy
The present invention refers to the use of sodium channel blockers such as tetrodotoxin or saxitoxin, its analogues/derivatives as well as their acceptable salts, for the production of a... |
|
|
8993618 |
Composition for treating influenza A (H1N1) virus and a preparation method therefor
New pharmaceutical compositions extracted from Ferula assa-foetida are confirmed to effectively treat influenza A (H1N1) virus. The extraction method of the new pharmaceutical compositions mainly... |
|
|
8987324 |
Use of simalikalactone E as an anticancer agent
The invention relates to Simalikalactone E (SkE) to be used for preventing and/or treating cancers. |
|
|
8980940 |
Stable cannabinoid compositions and methods for making and storing them
A composition comprising a high purity cannabinoid, an acid, and a pharmaceutically-acceptable solvent achieves room temperature stability for over 24 months. The acid improves the stability of... |
|
|
8975236 |
Dietary supplement composition of citrus derivatives
There is disclosed a dietary supplement composition of alkaloids and flavonoids extracted from citrus fruits that exhibits lipolytic and thermogenic activity and increases RMR, while at the same... |
|
|
8974363 |
Topical medicaments and methods for photodynamic treatment of disease
New photodynamic, topically-applicable medicaments and certain medical uses of such photodynamic medicaments for treatment of human or animal tissue are described, wherein a primary active... |
|
|
8952054 |
Small molecule inhibitors of MUC1 and methods of identifying the same
The invention provides methods for the identification of small molecules that inhibit MUC1 oligomerization, and the functions flowing therefrom. In addition, small molecules that prevent MUC1... |
|
|
8952003 |
Sterol derivative
The present invention provides a sterol derivative or a pharmaceutically acceptable salt thereof having an activity to promote proliferation of neural stem cells. Namely, the present invention... |
|
|
8927598 |
Treating oncogenic Ras driven cancers
Oncogenic Ras-driven cancer is treated with agent by interrupting pathway comprising activation of Akt by oncogenic Ras, activated Akt causing phosphorylation of eNOS at S1177 site of eNOS to... |
|
|
8912229 |
Taxane and abeo-taxane analogs
The present application discloses new taxane analogs, intermediates and methods for producing them. The present application is also directed to pharmaceutical formulations comprising abeo-taxanes... |
|
|
8906956 |
Composition comprising (−)-Δ9-trans-tetrahydrocannabinol
A composition comprising a tetrahydrocannabinol compound, a solvent and an acid, wherein the tetrahydrocannabinol compound may be Δ8 tetrahydrocannabinol, (−)-Δ9-trans-tetrahydrocannabinol or a... |
|
|
8895605 |
Pyrrolidine-substituted flavones as radio-sensitizers for use in the treatment of cancer
The present invention relates to a combination for the treatment of cancer wherein the combination exhibits a synergistic effect. The combination comprises radiation and at least one cyclin... |
|
|
8895576 |
Methods of use of cyclopamine analogs
The invention provides methods for treating various conditions using derivatives of cyclopamine having the following formula: |
|
|
8889176 |
Method of managing or treating pain
A composition for the intranasal delivery of fentanyl or a pharmaceutically acceptable salt thereof to an animal includes an aqueous solution of fentanyl or a pharmaceutically acceptable salt... |
|
|
8883192 |
Compositions and methods for reducing or preventing obesity
Compositions useful for weight management in an animal are disclosed. The compositions comprise one or more isoflavones or isoflavone metabolites, and in some embodiments include conjugated... |
|
|
8865235 |
Microbicidal and antiparasitic compositions
Pharmaceutical or dermo-dermo-cosmetic compositions for topical and intravaginal application for treatment of human and veterinary affections caused by anaerobic organisms or parasites comprising... |
|
|
8859462 |
Pest control composition
Disclosed is a pest control composition comprising at least one pyripyropene derivative of formula (I) or agriculturally and horticulturally acceptable salt thereof and at least one other pest... |
|
|
8835448 |
Methods and formulations for modulating lyn kinase activity and treating related disorders
The present invention relates to compounds and pharmaceutically acceptable salts thereof and formulations comprising the compounds or a pharmaceutically acceptable salts thereof that are useful in... |
|
|
8835489 |
Compounds of the pterocarpanquinone family, method for preparing the same, pharmaceutical composition containing the new compounds of the pterocarpanquinone family, uses and therapeutic method
This invention belongs to the chemical-pharmaceutical field. New compounds of pterocarpanquinone family presented in formula (I) according to this invention are capable to be activated by... |
|
|
8815844 |
Mitochondrial activity inhibitors of cancer-initiating cells and use thereof
The present invention relates to the compounds useful in the prevention and/or treatment of tumors. More specifically the present invention relates to inhibitors of the activity of the electron... |
|
|
8796327 |
Method for inhibiting production of cytokines of T helper cell type II and/or inhibiting production of chemokines using brazilin
A method for inhibiting the production of cytokines of T helper cell type II (Th2 cell) and/or inhibiting the production of chemokines in a mammal is provided, wherein the method comprises... |
|
|
8778372 |
Dual-action pest control formulation and method
The present disclosure provides a dual-action pest control formulation for controlling rodents and arthropods, the formulation including: a rodenticide; an insecticide; an optional attractant; and... |
|
|
8778914 |
Bisphosphonate-prodrugs
The present invention relates to a prodrug, comprising a pharmaceutically and/or diagnostically active compound, and one or more bisphosphonate groups, to a process for producing such a prodrug,... |
|
|
8778988 |
Endoperoxides and methods of photocatalytically synthesizing endoperoxides
A method of making an endoperoxide from a diene and oxygen in the presence of a photocatalyst having an excited state lifetime of at least 100 nanoseconds, the endoperoxide being represented by... |
|
|
8765803 |
Rab7 GTPase inhibitors and related methods of treatment
This invention relates to compounds and their use as inhibitors or activators of Rab7 GTPase to treat or prevent the onset of Rab 7 GTPase-associated disorders such as neuropathies, cancer,... |
|
|
8758832 |
Oral or enteral dosage forms containing phytochemicals from pomegranates
Nutraceutical compositions for improved administration of important phytochemicals from pomegranate to a human or animal. More particularly, enables oral or enteral dosage forms containing... |
|
|
8722727 |
Antifungal agents
Novel derivatives of enfumafungin are disclosed herein, along with' their pharmaceutically acceptable salts, hydrates and prodrugs. Also disclosed are compositions comprising such compounds,... |
|
|
8716328 |
Acid-labile lipophilic prodrugs of cancer chemotherapeutic agents
The present application discloses an acid labile lipophilic molecular conjugate of cancer chemotherapeutic agents and methods for reducing or substantially eliminating the side effects of... |
|
|
8709459 |
Triple-action pest control formulation and method
The present disclosure provides a triple-action pest control formulation for controlling rodents, insects, and terrestrial mollusks, the formulation including: a first active ingredient which is a... |
|
|
8686028 |
Substituted benzfurochromenes and related compounds for the prevention and treatment of bone related disorders
The present invention relates to novel substituted benzfurochromenes and related compounds having the general formula (I), salts and chiral, achiral derivatives thereof; wherein R1, R2, R3, R4,... |
|
|
8668921 |
Lipase inhibitors
The present invention provides lipase inhibitors containing dimers of flavan-3-ols derived from teas as well as foods and beverages and medicines containing said inhibitors. More specifically, the... |
|
|
8633203 |
Use of pterocarpans as active anti-cellulite ingredients
The invention relates to a cosmetic, dermatological or pharmaceutical preparation, containing one, two or more compounds of formula (I) and/or a pharmaceutically acceptable salt of a compound of... |
|
|
8623909 |
Prophylactic/therapeutic agents for lifestyle-related diseases
Disclosed is a method for screening a compound having an activity that selectively modulates an androgen receptor, comprising a step of measuring the mRNA expression level of prostate-specific... |
|
|
8623901 |
Compounds for the treatment of CNS disorders
The invention relates to novel 1,6-disubstituted pyrazolopyrimidinones of formula (I), in which Hc is a tetrahydropyranyl-group and R1 is the group V−W−*, whereby V and W independently of each... |
|
|
8618123 |
Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors
Disclosed are novel gamma secretase inhibitors of the formula (I): or a pharmaceutically acceptable salt, solvate, or ester thereof, wherein L1, n, X, Ar, Y, Z, Q, and Q1 are as defined herein.... |
|
|
8618161 |
Fluorescent polymeric materials containing lipid soluble rhodamine dyes
Fluorescent polymeric materials are disclosed comprising a polymeric particle and one or more lipid soluble rhodamine dyes, comprising the following core structure: wherein R11 and R15 are each H... |
|
|
8618125 |
Composition comprising hepatic therapeutic active for treating liver diseases, certain cancers and liver health maintenance
Compositions of hepatic therapeutic actives from one or more acridone compounds, one or more xanthone compounds, one or more thioxanthone compounds, one or more tocotrienol compounds, and one or... |
|
|
8586626 |
Metabolites of wortmannin analogs and methods of using the same
Novel metabolites of wortmannin and wortmannin analogs and their use in inhibiting PI-3 kinase activity in mammals and the treatment and prevention of cancer or tumor formation in a subject are... |
|
|
8580847 |
Antrocin containing pharmaceutical compositions for inhibiting cancer cells
This subject invention is directed to a method for inhibition of cancer cells, comprising administrating an effective amount of a compound of formula I (Sesquiterpene lactones, antrocin) or... |
|
|
8580772 |
Combination therapies using melengestrol acetate and zilpaterol or its salts
This invention generally relates to a method for promoting growth and increasing feed utilization efficiency in animals, and, more specifically, to combinations comprising zilpaterol (and salts... |
|
|
8575135 |
Antiviral compounds
The disclosure is related to anti-viral compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and... |
|
|
8569378 |
p27 protein inducer
The present invention provides a p27 protein inducing agent comprising a compound represented by general formula (11) below or pharmaceutically acceptable salt thereof as an active ingredient:... |
|
|
8568794 |
Topical and intravaginal microbicidal and antiparasitic compositions comprising quassinoids or quassinoid-containing plant extracts
Pharmaceutical or dermo-cosmetic compositions for topical and intravaginal application for treatment of human and veterinary affections caused by anaerobic organisms or parasites are provided... |
|
|
8563600 |
Diagnostic compounds
The Invention relates to conjugates of formula (III) or (IIIa), or a salt thereof, their use as radiopharmaceuticals, processes for their preparation, and synthetic intermediates used in such... |
|
|
8563599 |
Methods for synthesizing glycinols, glyceollins I and II, compositions of selected intermediates, and therapeutic uses thereof
Two distinct methods are disclosed and claimed for synthesizing glyceollin I plus glyceollin II as a mixture and as their pure forms. Stereochemical isomers and various synthetic intermediates are... |
|
|
8551448 |
Rotanone analogs: method of preparation and use
The present invention provides rotenone analogs and methods of making and using them. Labeled with single photon and positron emitting isotopes, the rotenone analogs of the present invention are... |
|
|
8524214 |
Polyal drug conjugates comprising variable rate-releasing linkers
Polyal-Drug conjugates comprising a variable rate-releasing linker are described along with methods of making such conjugates. Uses for such Polyal-Drug conjugates is also described. |
|
|
8518915 |
Use of mitochondrially-addressed compounds for preventing and treating cardiovascular diseases
The invention relates to pharmacology and medicine, in particular to a class of mitochondrially-addressed compounds which can be used in the pharmaceutical compositions of medicinal agents... |
|
|
8476311 |
Composition for treating influenza A (H1N1) virus and a preparation method therefor
New pharmaceutical compositions extracted from Ferula assa-foetida are confirmed to effectively treat influenza A (H1N1) virus. The extraction method of the new pharmaceutical compositions mainly... |
|
|
8476312 |
Composition comprising (−)-Δ9-trans-tetrahydrocannabinol
A composition comprising a tetrahydrocannabinol compound, a solvent and an acid, wherein the tetrahydrocannabinol compound may be Δ8 tetrahydrocannabinol, (−)-Δ9-trans-tetrahydrocannabinol or a... |